Showing results (101-110 of 169) with videos related to

Sort By:
Pageof 17
Future Oncology (London, England)|February 3, 2021
KEYNOTE-975 study design: a Phase III study of definitive chemoradiotherapy plus pembrolizumab in patients with esophageal carcinomaManish A Shah, Jaafar Bennouna, Toshihiko Doi, et al.
Future Oncology (London, England)|February 9, 2019
KEYNOTE-590: Phase III study of first-line chemotherapy with or without pembrolizumab for advanced esophageal cancerKen Kato, Manish A Shah, Peter Enzinger, et al.
Frontiers in Oncology|March 1, 2021
<i>nab</i>-Paclitaxel Plus Durvalumab in Patients With Previously Treated Advanced Stage Non-small Cell Lung Cancer (ABOUND.2L+)Daniel Morgensztern, Manuel Cobo Dols, Santiago Ponce Aix, et al.
JAMA Oncology|November 14, 2018
Continuation of Bevacizumab vs Cetuximab Plus Chemotherapy After First Progression in KRAS Wild-Type Metastatic Colorectal Cancer: The UNICANCER PRODIGE18 Randomized Clinical TrialJaafar Bennouna, Sandrine Hiret, Aurelie Bertaut, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 2, 2023
Prognostic score for synchronous metastatic rectal cancer: A real-world studyLéa Muzellec, Loïc Campion, Jean-Baptiste Bachet, et al.
JTO Clinical and Research Reports|January 24, 2025
Real-World Outcomes of Pralsetinib in RET Fusion-Positive NSCLCFrancesca Lucibello, Valérie Gounant, Mihaela Aldea, et al.
European Journal of Cancer (Oxford, England : 1990)|June 27, 2017
Prospective validation of a lymphocyte infiltration prognostic test in stage III colon cancer patients treated with adjuvant FOLFOXJean-François Emile, Catherine Julié, Karine Le Malicot, et al.
Neuroendocrinology|August 4, 2021
Oxaliplatin and 5-Fluorouracil in Advanced Well-Differentiated Digestive Neuroendocrine Tumors: A Multicenter National Retrospective Study from the French Group of Endocrine TumorsPaul Girot, Eric Baudin, Hélène Senellart, et al.
Cancers|January 12, 2021
The Caspase-1/IL-18 Axis of the Inflammasome in Tumor Cells: A Modulator of the Th1/Tc1 Response of Tumor-Infiltrating T Lymphocytes in Colorectal CancerLinda Bilonda Mutala, Cécile Deleine, Matilde Karakachoff, et al.
Clinical Colorectal Cancer|November 13, 2018
Rationale and Design of the IROCAS Study: Multicenter, International, Randomized Phase 3 Trial Comparing Adjuvant Modified (m) FOLFIRINOX to mFOLFOX6 in Patients With High-Risk Stage III (pT4 and/or N2) Colon Cancer-A UNICANCER GI-PRODIGE TrialJaafar Bennouna, Thierry André, Loïc Campion, et al.
Pageof 17